you are here: Home News Covishield

Covishield

Stopped manufacturing, supply of Covishield vaccine since December 2021: Serum Institute
Shreyas Talpade says his heart attack could be the side effect of Covid vaccine, 'I would not negate the theory'
AstraZeneca Pharma fall 3% despite healthy Q2 net profit, revenue growth
Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield
Covishield immune responses against Covid variants higher than Covaxin: Study
Serum Institute to start free COVID vaccine supply to government, other manufacturers await order
Serum Institute to provide 2 crore Covishield doses to central govt free of cost
Bill Gates, Serum Institute get Bombay HC notice after man claims Covishield side-effects killed daughter
HC seeks response from SII, others on plea demanding Rs 1,000 crore compensation for woman's death
Government nod to Corbevax as precaution dose for adults vaccinated with Covaxin, Covishield
Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
COVID-19 shots administered in India about to overtake count in all of Europe, North America
Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin
World's biggest vaccine maker Serum halts production with 200 million doses spare
India's 'warm' vaccine candidate effective against Delta, Omicron variants in mice: Study
Reduce time gap for COVID vaccine booster dose to six months: Serum Institute to govt
SII to give free Covishield vials to private vaccination centres to compensate for price difference
Moneycontrol Daily: Your Essential 7
Covaxin, Covishield prices slashed to Rs 225 per shot, a day before precaution drive starts
For future orders, SII to provide free replacement if vaccine expires: Adar Poonawalla
Huge response to COVID-19 shots for 12-14 age group; private hospitals keep away
Explainer: Intranasal vaccine against COVID-19 and why it is awaited so eagerly
Adar Poonawalla, CEO of vaccine maker Serum Institute, has a message for Novak Djokovic
Piles of unused COVID-19 jabs near expiry, private hospitals turn to government for bailout
Centre spent Rs 28,436 crore on vaccination this fiscal, leaving 27% of the allocated fund unspent

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Covishield

Stopped manufacturing, supply of Covishield vaccine since December 2021: Serum Institute

Shreyas Talpade says his heart attack could be the side effect of Covid vaccine, 'I would not negate the theory'

AstraZeneca Pharma fall 3% despite healthy Q2 net profit, revenue growth

Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield

Covishield immune responses against Covid variants higher than Covaxin: Study

Serum Institute to start free COVID vaccine supply to government, other manufacturers await order

Serum Institute to provide 2 crore Covishield doses to central govt free of cost

Bill Gates, Serum Institute get Bombay HC notice after man claims Covishield side-effects killed daughter

HC seeks response from SII, others on plea demanding Rs 1,000 crore compensation for woman's death

Government nod to Corbevax as precaution dose for adults vaccinated with Covaxin, Covishield

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

COVID-19 shots administered in India about to overtake count in all of Europe, North America

Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin

World's biggest vaccine maker Serum halts production with 200 million doses spare

India's 'warm' vaccine candidate effective against Delta, Omicron variants in mice: Study

Reduce time gap for COVID vaccine booster dose to six months: Serum Institute to govt

SII to give free Covishield vials to private vaccination centres to compensate for price difference

Moneycontrol Daily: Your Essential 7

Covaxin, Covishield prices slashed to Rs 225 per shot, a day before precaution drive starts

For future orders, SII to provide free replacement if vaccine expires: Adar Poonawalla

Huge response to COVID-19 shots for 12-14 age group; private hospitals keep away

Explainer: Intranasal vaccine against COVID-19 and why it is awaited so eagerly

Adar Poonawalla, CEO of vaccine maker Serum Institute, has a message for Novak Djokovic

Piles of unused COVID-19 jabs near expiry, private hospitals turn to government for bailout

Centre spent Rs 28,436 crore on vaccination this fiscal, leaving 27% of the allocated fund unspent